A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India
Condition:   Herpes Zoster Interventions:   Biological: HZ/su;   Drug: Placebo Sponsor:   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2022 Category: Research Source Type: clinical trials